|Awarded On||February 21, 2018|
|Title||Alliance for Colorectal Cancer Testing 2.0 (ACT 2.0)|
|Award Mechanism||Evidence-Based Cancer Prevention Services - Colorectal Cancer Prevention Coalition|
|Institution/Organization||The University of Texas M.D. Anderson Cancer Center|
|Principal Investigator/Program Director||Lewis Foxhall|
In Texas in 2017 there will be an estimated 9,690 new cases of colorectal cancer (CRC) and approximately 3,700 deaths making CRC 4th in new cancer cases and 2nd in numbers of deaths by cancer site (American Cancer Society, 2017). Texas ranks 43rd in fecal occult blood testing for those 50 and older, highlighting the population at risk, with significant variation by race/ethnicity, geographic region, insurance status, and access to prevention and treatment services (Centers for Disease & Prevention, 2014).
Interventions to increase colorectal cancer screening (CRCS) are needed to change the status quo and reach the 80% by 2018 screening goal of the American Cancer Society (ACS), Centers...